Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 23 | 2017 | 1007 | 4.720 |
Why?
|
| Conditioning, Operant | 19 | 2017 | 313 | 3.130 |
Why?
|
| Receptors, Dopamine D2 | 11 | 2017 | 475 | 2.440 |
Why?
|
| Self Administration | 23 | 2016 | 386 | 2.430 |
Why?
|
| Dopamine Agonists | 13 | 2017 | 355 | 2.140 |
Why?
|
| Receptors, Dopamine D1 | 8 | 2016 | 291 | 1.920 |
Why?
|
| Dopamine Uptake Inhibitors | 8 | 2013 | 312 | 1.780 |
Why?
|
| Cocaine-Related Disorders | 9 | 2013 | 460 | 1.650 |
Why?
|
| Muscarinic Agonists | 5 | 2013 | 87 | 1.570 |
Why?
|
| Receptors, Dopamine D3 | 5 | 2017 | 110 | 1.470 |
Why?
|
| Discrimination Learning | 5 | 2016 | 280 | 1.400 |
Why?
|
| Behavior, Animal | 13 | 2012 | 1881 | 1.270 |
Why?
|
| Receptor, Muscarinic M1 | 4 | 2013 | 24 | 1.260 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 5 | 2011 | 54 | 1.050 |
Why?
|
| Central Nervous System Stimulants | 6 | 2013 | 1148 | 1.000 |
Why?
|
| Receptor, Muscarinic M4 | 4 | 2013 | 12 | 0.990 |
Why?
|
| Food | 8 | 2017 | 770 | 0.980 |
Why?
|
| Choice Behavior | 3 | 2017 | 803 | 0.980 |
Why?
|
| Dopamine Antagonists | 8 | 2017 | 296 | 0.900 |
Why?
|
| Reinforcement Schedule | 8 | 2014 | 129 | 0.890 |
Why?
|
| Motor Activity | 8 | 2011 | 2714 | 0.770 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2017 | 10949 | 0.640 |
Why?
|
| Dextroamphetamine | 4 | 2013 | 129 | 0.610 |
Why?
|
| Receptors, Muscarinic | 2 | 2016 | 156 | 0.600 |
Why?
|
| Quinolines | 5 | 2011 | 730 | 0.590 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2009 | 422 | 0.580 |
Why?
|
| Pyridines | 5 | 2017 | 2822 | 0.560 |
Why?
|
| Thiadiazoles | 2 | 2013 | 55 | 0.550 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2017 | 8302 | 0.500 |
Why?
|
| Hyperkinesis | 2 | 2011 | 89 | 0.500 |
Why?
|
| Benzazepines | 8 | 2016 | 326 | 0.490 |
Why?
|
| Morpholines | 2 | 2017 | 573 | 0.450 |
Why?
|
| Alkaloids | 1 | 2014 | 190 | 0.440 |
Why?
|
| Aminopyridines | 2 | 2017 | 542 | 0.430 |
Why?
|
| Mice, Knockout | 12 | 2016 | 14556 | 0.380 |
Why?
|
| Antipsychotic Agents | 3 | 2009 | 3058 | 0.380 |
Why?
|
| Mice, Mutant Strains | 4 | 2009 | 1866 | 0.360 |
Why?
|
| Infusions, Intravenous | 4 | 2011 | 2272 | 0.360 |
Why?
|
| Food Preferences | 1 | 2013 | 399 | 0.350 |
Why?
|
| Haloperidol | 2 | 2009 | 397 | 0.340 |
Why?
|
| Nicotine | 1 | 2014 | 681 | 0.330 |
Why?
|
| Substance-Related Disorders | 3 | 2012 | 4259 | 0.330 |
Why?
|
| Rats | 14 | 2013 | 24273 | 0.310 |
Why?
|
| Animals | 37 | 2017 | 168788 | 0.310 |
Why?
|
| Models, Animal | 3 | 2011 | 2171 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 14 | 2012 | 21824 | 0.300 |
Why?
|
| Clozapine | 2 | 2009 | 498 | 0.300 |
Why?
|
| Food, Fortified | 1 | 2008 | 191 | 0.290 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 322 | 0.290 |
Why?
|
| Species Specificity | 5 | 2011 | 2480 | 0.290 |
Why?
|
| Mice, Inbred Strains | 4 | 2011 | 1827 | 0.280 |
Why?
|
| Receptor, Muscarinic M5 | 1 | 2005 | 1 | 0.270 |
Why?
|
| Dopamine | 2 | 2011 | 1591 | 0.270 |
Why?
|
| Piperazines | 3 | 2008 | 2491 | 0.260 |
Why?
|
| Mice | 23 | 2016 | 81178 | 0.260 |
Why?
|
| GABA Agonists | 1 | 2005 | 111 | 0.260 |
Why?
|
| Quinolones | 1 | 2008 | 367 | 0.250 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1028 | 0.250 |
Why?
|
| Tetrahydronaphthalenes | 4 | 2012 | 89 | 0.250 |
Why?
|
| Mice, Inbred DBA | 3 | 2011 | 642 | 0.240 |
Why?
|
| Orchiectomy | 1 | 2004 | 466 | 0.200 |
Why?
|
| Ovariectomy | 1 | 2004 | 661 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2008 | 985 | 0.200 |
Why?
|
| Receptors, GABA-A | 1 | 2005 | 627 | 0.190 |
Why?
|
| Mice, Inbred C3H | 2 | 2011 | 964 | 0.180 |
Why?
|
| Salicylamides | 3 | 2004 | 33 | 0.180 |
Why?
|
| Cues | 3 | 2013 | 873 | 0.180 |
Why?
|
| Benzamides | 2 | 2017 | 1378 | 0.170 |
Why?
|
| Male | 27 | 2017 | 350027 | 0.160 |
Why?
|
| Locomotion | 2 | 2011 | 378 | 0.140 |
Why?
|
| Ligands | 2 | 2017 | 3294 | 0.140 |
Why?
|
| Estradiol | 1 | 2004 | 2020 | 0.140 |
Why?
|
| Venoms | 1 | 2016 | 91 | 0.140 |
Why?
|
| Drug Tolerance | 1 | 2017 | 376 | 0.130 |
Why?
|
| Piperidines | 2 | 2017 | 1605 | 0.130 |
Why?
|
| Testosterone | 1 | 2004 | 2411 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 6386 | 0.110 |
Why?
|
| Macaca mulatta | 2 | 2014 | 2378 | 0.100 |
Why?
|
| Alcoholism | 1 | 2002 | 1906 | 0.100 |
Why?
|
| Oxotremorine | 1 | 2009 | 10 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 9735 | 0.090 |
Why?
|
| Ethanol | 1 | 2016 | 1342 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 4929 | 0.090 |
Why?
|
| Scopolamine | 1 | 2009 | 99 | 0.090 |
Why?
|
| Drug Interactions | 2 | 2007 | 1458 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6367 | 0.090 |
Why?
|
| Muscarinic Antagonists | 1 | 2009 | 137 | 0.080 |
Why?
|
| Drug Partial Agonism | 1 | 2008 | 25 | 0.080 |
Why?
|
| Indoles | 1 | 2017 | 1838 | 0.080 |
Why?
|
| Allosteric Regulation | 1 | 2009 | 408 | 0.080 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 418 | 0.080 |
Why?
|
| Extinction, Psychological | 1 | 2011 | 376 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2013 | 462 | 0.080 |
Why?
|
| Trihexyphenidyl | 1 | 2007 | 4 | 0.080 |
Why?
|
| Behavior | 1 | 2011 | 560 | 0.080 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 270 | 0.080 |
Why?
|
| Sex Factors | 2 | 2011 | 10396 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2011 | 2050 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1372 | 0.070 |
Why?
|
| Housing, Animal | 1 | 2005 | 48 | 0.070 |
Why?
|
| Female | 11 | 2014 | 380197 | 0.070 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 153 | 0.070 |
Why?
|
| Reflex | 1 | 2007 | 365 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3133 | 0.060 |
Why?
|
| Random Allocation | 1 | 2009 | 2427 | 0.060 |
Why?
|
| Dopamine Agents | 1 | 2005 | 189 | 0.060 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2004 | 41 | 0.060 |
Why?
|
| Phenotype | 3 | 2011 | 16365 | 0.060 |
Why?
|
| Peptides | 1 | 2016 | 4407 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1420 | 0.060 |
Why?
|
| Health | 1 | 2005 | 394 | 0.050 |
Why?
|
| Gene Targeting | 2 | 2004 | 880 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2002 | 379 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2886 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2002 | 295 | 0.050 |
Why?
|
| Genotype | 2 | 2007 | 12956 | 0.050 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2002 | 171 | 0.050 |
Why?
|
| Aggression | 1 | 2005 | 753 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 1161 | 0.040 |
Why?
|
| Vagina | 1 | 2004 | 825 | 0.040 |
Why?
|
| Wakefulness | 1 | 2005 | 1245 | 0.040 |
Why?
|
| Homozygote | 1 | 2002 | 1786 | 0.040 |
Why?
|
| Gene Expression | 1 | 2009 | 7799 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1903 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15070 | 0.030 |
Why?
|
| Heterozygote | 1 | 2002 | 2805 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2004 | 2586 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6101 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 7908 | 0.030 |
Why?
|
| Time Factors | 1 | 2013 | 40063 | 0.020 |
Why?
|
| Reward | 1 | 2016 | 941 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2007 | 6882 | 0.020 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2004 | 21 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 176 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 72280 | 0.010 |
Why?
|
| Amphetamines | 1 | 2004 | 148 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2004 | 303 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 29784 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 449 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 964 | 0.010 |
Why?
|
| Glycine | 1 | 2004 | 671 | 0.010 |
Why?
|
| Serine | 1 | 2004 | 828 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 895 | 0.010 |
Why?
|
| Sodium | 1 | 2004 | 1623 | 0.010 |
Why?
|
| Synapses | 1 | 2004 | 1729 | 0.010 |
Why?
|
| Humans | 2 | 2011 | 744220 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 3676 | 0.010 |
Why?
|
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_